Eric M. Attias
InvestorManaging Partner, Bio&Med Fund; Co-Managing Partner, Brain AI Fund; Founder at Forepont Capital Partners
New York
About
Eric M. Attias founded Forepont in 2017 and serves as managing partner of its Bio&Med Fund and co-managing partner of its Brain AI Fund. He has an investment and company-building background that includes early investments in Synchron and Precision Neuroscience, as well as building, acquiring, and selling companies such as Nexar (sold to UBP) and stakes tied to Allianz's AAAM and Ermitage. He previously managed a large alternative investment company and holds degrees in computer science (neural networks), engineering, and business administration.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Investments
Investor
Precision NeuroscienceSynchron
Per the firm's website.
